SEEGENE, INC. — Investor Relations & Filings
Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 자기주식처분결과보고서 | 2026-05-21 | Korean | |
| [기재정정]사업보고서 (2024.12) | 2026-05-15 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 연결재무제표기준영업(잠정)실적(공정공시) | 2026-05-08 | Korean | |
| 주요사항보고서(자기주식처분결정) | 2026-05-06 | Korean | |
| 현금ㆍ현물배당결정 | 2026-05-06 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46717192 | 자기주식처분결과보고서 | 2026-05-21 | Korean | ||
| 46368954 | [기재정정]사업보고서 (2024.12) | 2026-05-15 | Korean | ||
| 46368938 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 44132166 | 연결재무제표기준영업(잠정)실적(공정공시) | 2026-05-08 | Korean | ||
| 41742860 | 주요사항보고서(자기주식처분결정) | 2026-05-06 | Korean | ||
| 41742845 | 현금ㆍ현물배당결정 | 2026-05-06 | Korean | ||
| 41742797 | 중간(분기)배당을위한주주명부폐쇄(기준일)결정 | 2026-05-06 | Korean | ||
| 41624432 | 자기주식처분결과보고서 | 2026-05-06 | Korean | ||
| 39045333 | 결산실적공시예고 | 2026-04-30 | Korean | ||
| 38431556 | 주식등의대량보유상황보고서(일반) | 2026-04-29 | Korean | ||
| 33982048 | 주요사항보고서(자기주식처분결정) | 2026-04-10 | Korean | ||
| 33955007 | 자기주식처분결과보고서 | 2026-04-10 | Korean | ||
| 33057253 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 33057240 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33057175 | 기업가치제고계획(자율공시) | 2026-03-27 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
SEEGENE, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17243/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17243 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17243 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17243 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17243}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SEEGENE, INC. (id: 17243)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.